Cite
APA Citation
Jiang, J., Li, S., Shan, X., Wang, L., Ma, J., Huang, M., Dong, L., & Chen, F. (2020). preclinical safety profile of disitamab vedotin：a novel anti-HER2 antibody conjugated with MMAE. Toxicology letters, 324, 30–37. http://access.bl.uk/ark:/81055/vdc_100104110723.0x00002b